. 2016 May 27;6:26745. doi: 10.1038/srep26745

Table 2. Relationships of cIMT and fasting TMAO levels with selected parameters at baseline.

	TMAO levels		cIMT
	r	p	r	p
Age	0.23	0.0006	0.64	<0.0001
Body mass index	0.14	0.03	0.19	0.004
Total body fat _MRT	0.07	0.27	0.06	0.42
Visceral fat_MRT	0.12	0.07	0.40	<0.0001
Liver fat_MRS	0.05	0.45	0.23	0.0005
Fasting glucose	0.15	0.02	0.25	0.0002
Fasting insulin	0.02	0.72	0.12	0.07
2 hr glucose	−0.08	0.25	0.18	0.008
Total cholesterol	0.14	0.04	0.17	0.01
HDL-cholesterol	0.01	0.84	−0.12	0.08
LDL-cholesterol	0.14	0.03	0.12	0.005
Triglycerides	0.07	0.29	0.12	0.07
Apolipoprotein B	0.18	0.009	0.27	<0.0001
Hs-CRP	−0.01	0.88	0.13	0.06
TNF-alpha^*	0.27	0.001	0.10	0.22
Systolic BP	0.006	0.93	0.19	0.005
Diastolic BP	−0.005	0.94	0.12	0.09
eGFR	−0.14	0.04	−0.06	0.36
HOMA-IR	0.05	0.48	0.15	0.02
Insulin sensitivity_OGTT	−0.002	0.98	−0.18	0.009
Insulin sensitivity_Clamp^#	−0.03	0.75	−0.13	0.10
Insulin clearance	0.03	0.62	−0.11	0.12

r, Pearson correlation coefficient; *Only available in 144 subjects. ^#Only available in 167 subjects. BIA, body impedance; MRT, magnetic resonance tomography; MRS, magnetic resonance spectroscopy. MRT: magnetic resonance tomography, MRS: magnetic resonance spectroscopy; eGFR: estimated glomerular filtration rate; HOMA-IR: homeostatic model assessment of insulin resistance; cIMT: carotid intima-media thickness; TMAO: trimethylamine N-oxide; BP: blood pressure.